# The Prognostic Significance of Fibrosis Detection in Cardiomyopathy

> **NCT00930735** · — · UNKNOWN · sponsor: **Royal Brompton & Harefield NHS Foundation Trust** · enrollment: 3000 (estimated)

## Conditions studied

- Cardiomyopathy
- Coronary Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00930735
- **Lead sponsor:** Royal Brompton & Harefield NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-01
- **Primary completion:** 2020-04-30
- **Final completion:** 2025-07
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2018-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930735, "The Prognostic Significance of Fibrosis Detection in Cardiomyopathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00930735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*